Future Tech Jobs
Future Tech Jobs
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to being...
Leads clinical development strategy for oncology assets, defining scientific narrative, benefit-risk frameworks, and decision pathways across the lifecycle. Acts as clinical authority within cross-functional teams and external engagements, leveraging advanced analytics and AI to accelerate drug development. Focuses on integrating clinical, regulatory, and commercial strategies to deliver impactful cancer therapies.
This role leads clinical development for Internal Medicine assets within Pfizer's Research & Development division, serving as the primary clinical accountable leader for global drug development programs. The position involves end-to-end responsibility for clinical strategy, trial design, regulatory submissions, and cross-functional team leadership across a complex matrix environment. It also includes engagement with external stakeholders, patient advocacy groups, and oversight of safety and lifecycle planning, with a focus on obesity and related therapeutic areas.
Lead and develop GMP/GDP audit strategy for a key technology area such as sterile biologics or medical devices, ensuring compliance with global regulations and emerging trends. Conduct complex audits across Pfizer facilities, contract manufacturers, and suppliers, while coaching auditors and driving continuous improvement in quality systems. Collaborate with cross-functional teams to assess risks, resolve findings, and prepare for regulatory inspections.
This role involves leading pharmacovigilance and risk management strategies for GSK's global assets, with a focus on safety evaluation in immunology and other therapeutic areas. The Scientific Director will oversee safety governance, lead cross-functional teams, and ensure compliance with global regulations. They will analyze clinical data, manage safety issues, and contribute to regulatory submissions and long-term clinical strategy.
This role involves leading pharmacovigilance and risk management strategy for GSK's global assets, with a focus on safety evaluation in immunology and other therapeutic areas. The Scientific Director will lead safety governance, contribute to regulatory submissions, and manage cross-functional teams to address product safety issues. They will also represent GSK in interactions with regulatory authorities and ensure compliance with global pharmacovigilance standards.
This role involves shaping the strategic advancement of multiple oncology development programmes at GSK, focusing on scientific alignment, portfolio coherence, and clinical innovation across assets. The Senior Director will provide expert guidance on disease biology, biomarker strategies, and trial design while driving cross-programme integration and external engagement. It is a senior individual contributor position operating at the intersection of science, development, and portfolio leadership in oncology.
Leads cross-programme scientific strategy and integration across GSK’s oncology portfolio, with a focus on hematology. Provides expert guidance on disease biology, biomarker strategies, and clinical development innovation across multiple assets. Champions data-driven decision-making, trial innovation, and external engagement to align portfolio direction and accelerate development.
Leads scientific and strategic integration across multiple oncology development programmes, ensuring alignment with disease biology, biomarker strategies, and clinical innovation. Acts as a cross-portfolio expert to shape development pathways, drive trial innovation, and support regulatory engagement. Focuses on advancing assets in high-unmet-need cancers through pan-asset insights and data-driven decision-making.
A senior scientific leadership role focused on pharmacovigilance and safety risk management for GSK's global pharmaceutical assets. The role involves leading safety strategy, evaluating clinical data, and ensuring regulatory compliance across development and post-marketing stages. It requires deep expertise in drug safety, cross-functional leadership, and communication with regulatory authorities.
Leads scientific and strategic integration across multiple oncology development programmes, ensuring alignment with disease biology, biomarker strategies, and clinical innovation. Acts as a cross-asset expert, shaping portfolio-level decision-making and advancing trial design through emerging technologies like AI. Works closely with Clinical Development Leads and senior governance to drive coherent, efficient development across GSK’s oncology pipeline.
Leads scientific and strategic integration across multiple oncology development programs, ensuring alignment with disease biology, biomarker strategies, and clinical innovation. Acts as a cross-asset expert to drive portfolio coherence, clinical trial design, and engagement with external advisors. Focuses on advancing high-impact cancer therapies through data-driven decision-making and emerging technologies like AI.
Leads scientific and strategic integration across GSK's hematology oncology portfolio, ensuring cross-program alignment and innovation in clinical development. Provides expert guidance on disease biology, biomarker strategies, and trial design while shaping portfolio-level decision-making. Operates as a senior individual contributor interfacing with clinical teams, external experts, and regulatory bodies.
Leads cross-programme scientific strategy and integration across GSK’s hematology oncology portfolio, ensuring alignment in clinical development, biomarker strategies, and innovative trial design. Acts as a senior scientific partner to Clinical Development Leads and drives data-driven decision-making using emerging technologies like AI. Operates at the portfolio level to shape disease-area strategy and support regulatory and governance engagement.
Lead scientific and strategic integration across GSK's hematology oncology portfolio, ensuring alignment of clinical development programmes, biomarker strategies, and innovative trial designs. Drive cross-asset coordination and decision-making at the disease level, leveraging deep oncology expertise and emerging technologies like AI. Engage with internal stakeholders and external experts to shape portfolio direction and regulatory strategy.
